DALY JAMES M 1560782 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-09 | 2023-05-05 | 2023-05-05 | 4 | Daly James M | DIRECTOR | acq | 8065.0 | 19.91 | 0.6 | 0.0 | Direct | Common Stock | HALOZYME THERAPEUTICS, INC. | code A | 40503.0 | 135.37 (HALO) |
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Daly James M | DIRECTOR | acq | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 18002.0
|
162.63 (ACAD) |
| 2023-08-15 | 2023-08-11 | 2023-08-11 to 2023-08-14 | 4 | Daly James M | DIRECTOR | dsp | 20000.0 | 49.38 | 1.52 | 43.73 | Direct | Common Stock | HALOZYME THERAPEUTICS, INC. | code S | 20503.0
|
131.92 (HALO) |
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Daly James M | DIRECTOR | acq | 1198.0 | 100.0 | 0.66 | 0.0 | Direct | Common Stock | MADRIGAL PHARMACEUTICALS, INC. | code A | 1198.0 | 18.29 (MDGL) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 to 2024-04-02 | 4 | Daly James M | DIRECTOR | acq | 32489.0 | 100 | 16.33 | 102.23 | Direct | Common Stock | MADRIGAL PHARMACEUTICALS, INC. | code M | 12110.0
|
19.9 (MDGL) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 to 2024-04-02 | 4 | Daly James M | DIRECTOR | dsp | 32489.0 | 96.44 | 16.33 | 252.97 | Direct | Common Stock | MADRIGAL PHARMACEUTICALS, INC. | code S | 1198.0
|
19.9 (MDGL) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-09 | 2023-05-05 | 2023-05-05 | 4 | Daly James M | DIRECTOR | acq | 11371.0 | 100.0 | 0.84 | 31.0 | Direct | Option To Purchase Common Stock | HALOZYME THERAPEUTICS, INC. | code A | 11371.0 | 135.37 (HALO) |
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Daly James M | DIRECTOR | acq | 11045.0 | 100.0 | 0.68 | 23.9 | Direct | Director Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 11045.0 | 162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Daly James M | DIRECTOR | dsp | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0
|
162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Daly James M | DIRECTOR | acq | 6652.0 | 100.0 | 0.41 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 6652.0 | 162.63 (ACAD) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 to 2024-04-02 | 4 | Daly James M | DIRECTOR | dsp | 32489.0 | 100.0 | 16.33 | 102.23 | Direct | Stock Option (Right To Buy) | MADRIGAL PHARMACEUTICALS, INC. | code M | 0.0
|
19.9 (MDGL) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)